Carinne Brouillon

Carinne Brouillon, PharmD, serves as the Head of Human Pharma and a member of the Board of Managing Directors at Boehringer Ingelheim since May 2018, overseeing the global Human Pharma Business Unit. Additionally, Carinne holds the position of Head of Global Therapeutic Areas at Munich Re since April 2021 and is a member of the Supervisory Board at The Janssen Pharmaceutical Companies of Johnson & Johnson, having previously held roles including Global Commercial Strategy Leader for Neuroscience at Janssen Therapeutics US from June 2012 to June 2014 and President of Janssen-Cilag from 1999 to May 2012. Carinne's educational background includes a Doctor's Degree in Pharmacy and a Master's degree in Marketing/Marketing Management from Université de Lyon.